Healthcare · Vaccine antigens production

Vaccine antigens production in Colombia in 2026

Colombia produces no vaccine antigens of its own (8 million doses in 2026), ranking 32nd globally. The country relies entirely on imports of finished vaccines and bulk antigens, primarily from India, China, and Europe. The absence of domestic production stems from high capital costs for biotech facilities and lengthy certification processes. Instead, Colombia focuses on expanding vaccination programs and cold-chain logistics.

Data for 2026 · unit: million doses
Position

Colombia world ranking

#32 / 197

Country position on the scale from last to first place for this indicator.

CO
#32
#197#1
Trend

Change over time

Change in indicator over the available period.

1
1950
2
1990
5
2000
2
2010
5
2020
8
2025
8
2026

Values — million doses

Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Vaccine antigens production in Colombia — how much?
Based on 2026 data — 8 million doses. This is rank #32 out of 197 countries.
What is Colombia's rank by Vaccine antigens production?
Colombia ranks #32 out of 197 countries in the world ranking by «Vaccine antigens production».
How has Vaccine antigens production changed in Colombia?
Over the available period the indicator changed from 1 to 8 million doses.